Connection
Larry Moreland to Dose-Response Relationship, Immunologic
This is a "connection" page, showing publications Larry Moreland has written about Dose-Response Relationship, Immunologic.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.037 |
|
|
|
-
Moreland LW, Heck LW, Koopman WJ, Saway PA, Adamson TC, Fronek Z, O'Connor RD, Morgan EE, Diveley JP, Chieffo NM, et al. V beta 17 T-cell receptor peptide vaccine. Results of a phase I dose-finding study in patients with rheumatoid arthritis. Ann N Y Acad Sci. 1995 Jul 07; 756:211-4.
Score: 0.029
-
Drevlow BE, Lovis R, Haag MA, Sinacore JM, Jacobs C, Blosche C, Landay A, Moreland LW, Pope RM. Recombinant human interleukin-1 receptor type I in the treatment of patients with active rheumatoid arthritis. Arthritis Rheum. 1996 Feb; 39(2):257-65.
Score: 0.008